ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CGCP Capital Group Fixed Income ETF Trust

22.48
0.00 (0.00%)
Pre Market
Last Updated: 09:09:54
Delayed by 15 minutes
Name Symbol Market Type
Capital Group Fixed Income ETF Trust AMEX:CGCP AMEX Exchange Traded Fund
  Price Change % Change Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 22.48 0 09:09:54

Cardiogenesis Corporation Presentation at OneMedForum 2010 Now Available on Company's Website

21/01/2010 6:23pm

PR Newswire (US)


Capital Group Fixed Inco... (AMEX:CGCP)
Historical Stock Chart


From Jun 2019 to Jun 2024

Click Here for more Capital Group Fixed Inco... Charts.
IRVINE, Calif., Jan. 21 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP), today announced that the corporate overview presented by Executive Chairman, Paul J. McCormick on January 12, 2010 at the OneMedForum is now available on its website. Interested investors may view the video and the accompanying slides by going to the Company's website (http://www.cardiogenesis.com/) and clicking on the Investors link and then OneMedForum Webcast. About Cardiogenesis Corporation Cardiogenesis is a medical device company specializing in the therapies for the treatment of chronic cardiac ischemia. The company's market leading Holmium:YAG laser system and disposable fiber-optic accessories are used to perform a FDA-cleared surgical procedure known as Transmyocardial Revascularization (TMR) to treat patients suffering from angina. Surgical products and accessories for the Cardiogenesis TMR procedure, which are marketed in the U.S. and around the world, have been shown to reduce angina and improve the quality of life in patients with coronary artery disease. For more information on the company and its products, please visit the Cardiogenesis company website at http://www.cardiogenesis.com/ or the direct to patient website at http://www.heartofnewlife.com/. DATASOURCE: Cardiogenesis Corporation CONTACT: Paul McCormick, Executive Chairman of Cardiogenesis Corporation, +1-949-420-1808 Web Site: http://www.cardiogenesis.com/ http://www.heartofnewlife.com/

Copyright

1 Year Capital Group Fixed Inco... Chart

1 Year Capital Group Fixed Inco... Chart

1 Month Capital Group Fixed Inco... Chart

1 Month Capital Group Fixed Inco... Chart